1 – 48 of 48
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
(
- Contribution to journal › Article
-
Mark
Joint modeling of multistate and nonparametric multivariate longitudinal data
(
- Contribution to journal › Article
- 2022
-
Mark
Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study
(
- Contribution to journal › Article
-
Mark
Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden
(
- Contribution to journal › Article
-
Mark
Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies
(
- Contribution to journal › Article
-
Mark
Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA
(
- Contribution to journal › Article
-
Mark
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
(
- Contribution to journal › Article
- 2021
-
Mark
Complete blood counts with red blood cell determinants associate with reduced beta-cell function in seroconverted Swedish TEDDY children
(
- Contribution to journal › Article
-
Mark
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study : TEFA
(
- Contribution to journal › Article
- 2019
-
Mark
Metabolite-related dietary patterns and the development of islet autoimmunity
(
- Contribution to journal › Article
- 2018
-
Mark
Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort
(
- Contribution to journal › Article
-
Mark
Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies
(
- Contribution to journal › Article
-
Mark
Reduction in White Blood Cell, Neutrophil, and Red Blood Cell Counts Related to Sex, HLA, and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes
(
- Contribution to journal › Article
- 2017
-
Mark
Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity : the TEDDY study
(
- Contribution to journal › Article
-
Mark
Analgesic antipyretic use among young children in the TEDDY study : No association with islet autoimmunity
(
- Contribution to journal › Article
-
Mark
An Increased Diagnostic Sensitivity of Truncated GAD65 Autoantibodies in Type 1 Diabetes May Be Related to HLA-DQ8
(
- Contribution to journal › Article
- 2016
-
Mark
Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study
(
- Contribution to journal › Article
- 2015
-
Mark
Role of Type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY Study.
(
- Contribution to journal › Article
-
Mark
Doubly reactive INS-IGF2 autoantibodies in children with newly diagnosed autoimmune (type 1) diabetes.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients.
(
- Contribution to journal › Article
- 2014
-
Mark
Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
(
- Contribution to journal › Article
- 2013
-
Mark
Autoimmunity against INS-IGF2 expressed in human pancreatic islets.
(
- Contribution to journal › Article
- 2011
-
Mark
HLA Genes, Islet Autoantibodies and Residual C-Peptide at the Clinical Onset of Type 1 Diabetes Mellitus and the Risk of Retinopathy 15 Years Later
(
- Contribution to journal › Article
-
Mark
Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics.
(
- Contribution to journal › Article
-
Mark
Beta-cell function and metabolic control in Latent Autoimmune Diabetes in Adults with early insulin versus conventional treatment: a 3-year follow-up
(
- Contribution to journal › Article
-
Mark
Excess mortality in middle-aged men with diabetes aged 15-34 years at diagnosis.
(
- Contribution to journal › Article
- 2010
-
Mark
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies
(
- Contribution to journal › Article
-
Mark
C-peptide in dried blood spots.
(
- Contribution to journal › Article
-
Mark
Comparison of measurements of autoantibodies to glutamic acid decarboxylase and islet antigen-2 in whole blood eluates from dried blood spots using the RSR-enzyme linked immunosorbent assay kits and in-house radioimmunoassays.
(
- Contribution to journal › Article
- 2008
-
Mark
Early insulin treatment in latent autoimmune diabetes in adults (LADA) did not improve residual beta cell function or metabolic control
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.391-391(
- Contribution to journal › Published meeting abstract
-
Mark
Seasonality of month of birth differs between type 1 diabetes patients with pronounced beta-cell autoimmunity and individuals with lesser or no beta-cell autoimmunity
(
- Contribution to journal › Article
-
Mark
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.
(
- Contribution to journal › Article
-
Mark
Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden.
(
- Contribution to journal › Article
-
Mark
A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
(
- Contribution to journal › Article
-
Mark
The Environmental Determinants of Diabetes in the Young (TEDDY) Study
(
- Contribution to journal › Article
- 2007
-
Mark
Islet cell autoantibody levels after the diagnosis of young adult diabetic patients
(
- Contribution to journal › Article
-
Mark
Presence of GAD-antibodies during gestational diabetes predicts type 1 diabetes.
(
- Contribution to journal › Article
-
Mark
No evidence of association of the PDCD1 gene with Type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
(
- Contribution to journal › Article
-
Mark
Latent autoimmune diabetes in adults in a South Asian population of the UK
(
- Contribution to journal › Article
- 2004
-
Mark
Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes
(
- Contribution to journal › Article
- 2002
-
Mark
GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoinimune diabetes
(
- Contribution to journal › Letter
- 2000
-
Mark
Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus - A nationwide study
(
- Contribution to journal › Article
-
Mark
The length of the CTLA-4 microsatellite (AT)(N)-repeat affects the risk for type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Prognostic factors for the course of β cell function in autoimmune diabetes
(
- Contribution to journal › Article
-
Mark
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
(
- Contribution to journal › Article
- 1999
-
Mark
Species-specific autoantibodies in type 1 diabetes
(
- Contribution to journal › Article